Results 61 to 70 of about 28,269 (176)

EPIDEMIOLOGY AND PREVENTION OF MENINGOCOCCAL DISEASE: A CRITICAL APPRAISAL OF VACCINE POLICIES

Педиатрическая фармакология, 2012
Meningococcal disease is characterized by a marked variation in incidence and serogroup distribution by region and over time. In several European countries, Canada and Australia, immunization programs, including universal vaccination of infants or ...
Marco AP Safadi, E David G Mcintosh
doaj   +1 more source

Vaccine Coverage and Vaccination Delays in Children With Chronic Illness: A French Multicentre Point‐Prevalence Survey

Acta Paediatrica, EarlyView.
F. Dubos, C. Santy, J. Toubiana, M. Caseris, J. Gaschignard, A. Morand, P. Minodier, Z. Maakaroun‐Vermesse, E. Launay, M. Lorrot, C. Brehin, I. Hau, E. Jeziorski, A. Tran, A. Agnani, A. Flammang, M. Meurin, M. Lagrée, D. Diallo   +18 more
wiley   +1 more source

Stakeholders' perspectives on integrating point‐of‐care diagnostics into forensic death investigations in South Africa

Journal of Forensic Sciences, Volume 71, Issue 5, Page 2182-2192, September 2026.
Abstract Unnatural and unexplained deaths present critical challenges to the criminal justice, medico‐legal, and public health systems. This study explored forensic professionals' perspectives on the integration of point‐of‐care (POC) diagnostics into unnatural death investigations in South Africa.
Sebueng Ramatsokotla, Bathabile Soul, Kuhlula Maluleke, Lucinda Evert, Stefan Jansen van Vurren, Bettina Chale‐Matsau, Susan Mabotja, Evans Duah, Tivani Mashamba‐Thompson   +8 more
wiley   +1 more source

Editorial: Meningococcal disease

Communicable Diseases Intelligence, 2001
This article published in Communicable Diseases Intelligence Volume 25, No 3, August 2001 contains an editorial on meningococcal disease.
P, Roche, J, Spencer, A, Marianos
openaire   +2 more sources

Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German–Austrian Expert Opinion Paper

European Journal of Neurology, Volume 33, Issue 9, September 2026.
ABSTRACT Background The therapeutic landscape of generalised myasthenia gravis (gMG) has evolved substantially with the approval of targeted immunotherapies, including complement C5 inhibitors (C5‐I) and neonatal Fc receptor inhibitors (FcRn‐I). While pivotal trials have demonstrated marked efficacy in defined subgroups, real‐world experience reveals ...
Andreas Meisel, Adela Della Marina, Paolo Doksani, Tim Hagenacker, Christoph Kleinschnitz, Heidrun H. Krämer, Jan D. Lünemann, Sven G. Meuth, Tobias Ruck, Ulrike Schara‐Schmidt, Christiane Schneider‐Gold, Benedikt Schoser, Michael Schroeter, Charlotte Schubert, Jörn Peter Sieb, Fritz Zimprich, Jana Zschüntzsch, Sarah Hoffmann   +17 more
wiley   +1 more source

Prevention of Meningococcal Disease: Knowledge, Attitudes, and Practices of General Practitioners and Primary Care Pediatricians in South Italy

Vaccines
Background: The purpose of this study was to evaluate the knowledge, attitude, and current practices about prevention of meningococcal disease among general practitioners (GPs) and primary care pediatricians (PCPs) in Italy.
Silvia Angelillo, Concetta Paola Pelullo, Francesca Licata, Raffaele Lanzano, Francesco Napolitano, Gabriella Di Giuseppe   +5 more
doaj   +1 more source

An Approach to Antibody‐Mediated Rejection in Pediatric Liver Transplantation

Pediatric Transplantation, Volume 30, Issue 9, September 2026.
ABSTRACT Antibody‐mediated rejection (AMR) is an important but infrequent cause of pediatric liver allograft injury. There is a lack of standardized guidance, and treatment approaches vary across institutions. A writing group from the Society of Pediatric Liver Transplantation conducted a comprehensive review of the published literature and collected ...
Catalina Jaramillo, Parmjeet Randhawa, Amrita Narang, Alison J. Gareau, Jody Weckwerth, Alisha Mavis, George Mazariegos, Katryn Furuya, Nanda Kerkar   +8 more
wiley   +1 more source

Short‐Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey‐Based Surveillance Study

Medical Journal of Australia, Volume 224, Issue 9, September 2026.
ABSTRACT Objective To examine short‐term safety outcomes following vaccination at 2‐, 4‐, 6‐ and 12‐month timepoints, comparing infants receiving meningococcal B (MenB) vaccines concomitantly with National Immunisation Program (NIP) vaccines to those receiving vaccines at separate visits. Study Type Observational cohort survey study.
Thuy Nguyen, Evelyn C. S. Tay, Michael Dymock, Thomas L. Snelling, Lucy Dawes, Julie Marsh, Yue Wu, Alan Leeb, Nicholas Wood, Lucy Deng   +9 more
wiley   +1 more source

Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis

mBio, 2018
Pediatric meningococcal sepsis often results in morbidity and/or death, especially in young children. Our understanding of the reasons why young children are more susceptible to both the meningococcal infection itself and a more fulminant course of the ...
Noortje de Haan, Navin P. Boeddha, Ebru Ekinci, Karli R. Reiding, Marieke Emonts, Jan A. Hazelzet, Manfred Wuhrer, Gertjan J. Driessen   +7 more
doaj   +1 more source

Meningococcal and pneumococcal disease [PDF]

Paediatrics & Child Health, 2002
The licensure of new vaccines in 2001 in Canada means that pneumococcal and group C meningococcal infections can be added to the list of vaccine-preventable diseases. The successful control of these two diseases will require all provincial and territorial governments in Canada to add the new vaccines to their routine immunization programs ...
openaire   +2 more sources